The world loses nearly $1 trillion a year to the systematic underpricing of women's health. The executive summary of Undervalued to Unavoidable introduces the argument, the framework, and the investment case built on data from McKinsey, the Lancet, the World Bank, and more.

This guide introduces the book’s central argument, the framework it’s built on, and the case for why women’s health is one of the most consequential investment decisions of the next decade.
Why the infrastructure framing changes the financial case entirely
An overview of the five pillars that structure the book’s full argument
Where the biggest returns are hiding and why most institutions haven’t moved yet
Marissa Fayer has spent 25 years operating inside the systems this book is about, as a CEO, engineer, board member, and founder in medtech and AI diagnostics.
-
CEO of an FDA-cleared AI diagnostics company
-
Nonprofit founder, operating in 12 countries
-
25 years in medtech, from Hologic to Maquet
-
Serves on investment committees and boards
Get the executive summary for a preview of the full infrastructure argument.